Genmab
GMAB
#1366
Rank
C$17.37 B
Marketcap
$27.76
Share price
2.51%
Change (1 day)
-29.35%
Change (1 year)

Earnings for Genmab (GMAB)

Earnings in 2024 (TTM): C$1.82 Billion

According to Genmab's latest financial reports the company's current earnings are C$3.10 Billion. , an increase over its 2023 earnings that were of C$1.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genmab from 2009 to 2024

Annual earnings

Year Earnings Change
2024 C$1.82 B63.99%
2023 C$1.11 B-17.29%
2022 C$1.34 B55.87%
2021 C$0.86 B-31.09%
2020 C$1.24 B111.51%
2019 C$0.59 B69.44%
2018 C$0.34 B49.63%
2017 C$0.23 B3.27%
2016 C$0.22 B46.33%
2015 C$0.15 B117.13%
2014 C$71.03 M329.17%
2013 C$16.55 M-159.26%
2012 -C$27.93 Million-48.96%
2011 -C$54.73 Million90.86%
2010 -C$28.68 Million-67.46%
2009 -C$88.12 Million